New Radiation Oncologist Joins Fox Chase Cancer Center
PHILADELPHIA (Sept. 10, 2002)-Steven J. Feigenberg, M.D., of Radnor, Pa., has joined Fox Chase Cancer Center's department of radiation oncology as a staff radiation oncologist. Feigenberg is an expert in radiation therapy for brain and lung cancers.
Feigenberg's clinical focus includes using the latest radiation therapy technologies to treat people with brain tumors and lung cancer. He has a leading role in developing image-guided stereotactic radiosurgery at Fox Chase.
Traditionally, this procedure has allowed one-time use of high-dose radiation to treat patients with cancers affecting the brain, including primary brain tumors and cancers that have spread (metastasized) to the brain from other organs. At Fox Chase, Feigenberg is working with Benjamin Movsas, M.D., vice chairman of radiation oncology, to develop radiosurgery for other sites in the body, such as lung cancer and other cancers that have metastasized to the lung and liver.
Born in Norristown, Pa., Feigenberg graduated with honors from Drexel University in 1991 with a B.S. in chemical engineering and a minor in chemistry. He received his M.D. from Hahnemann University School of Medicine in Philadelphia in 1997.
Feigenberg served an internship in internal medicine at Temple University Hospital in Philadelphia in 1998. He then completed his residency in radiation oncology at the University of Florida in Gainesville, where he was chief resident from 2000 until joining Fox Chase.
At the University of Florida, Feigenberg received the Department of Radiation Oncology "Talken" Award for 2000 for the best resident research project and the Roentgen Resident Research Award for 2001 presented by the RSNA Research and Education Foundation. He is a member of the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology and the American Medical Association.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.